Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Covenant Research and Clinics (United States) | Researchclopedia

Back to institutions

Covenant Research and Clinics (United States)

Sarasota, Floridacompany

20

Works

1,354

Citations

11

h-index

Top Research Topics

Liver Disease Diagnosis and Treatment Liver Diseases and Immunity Fibroblast Growth Factor Research

Top Researchers

Guy Neff Université de Tours

241 works11,108 citationsh-index: 47

Recent Research

P47 Efficacy and safety of seladelpar as monotherapy in patients with primary biliary cholangitis and intolerance to ursodeoxycholic acid

Stuart C. Gordon,Guy Neff,et al.

20250 citations

Pediatric Hepatobiliary Diseases and Treatments

Hepatocellular Carcinoma Treatment and Prognosis

Hepatitis C virus research

Liver Disease and Transplantation

Pancreatitis Pathology and Treatment

Alcohol Consumption and Health Effects

Diet, Metabolism, and Disease

Thyroid Disorders and Treatments

Diabetes Treatment and Management

Bryan Diaz Peruvian University of Applied Sciences

10 works103 citationsh-index: 6

Richard C. Lansky

5 works27 citationsh-index: 1

J.C. Hart Covenant Research and Clinics (United States)

3 works1 citationsh-index: 1

Ms. S. Cubberley Duke University

1 works1 citationsh-index: 1

Julia Surow Covenant Research and Clinics (United States)

1 works0 citationsh-index: 0

Shared mechanistic pathways of glucagon signalling: Unlocking its potential for treating obesity, metabolic dysfunction‐associated steatotic liver disease, and other cardio‐kidney‐metabolic conditions

20254 citations

Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis

Eric Lawitz,Mandy Fraessdorf,et al.

202441 citations

Safety and Efficacy of Efruxifermin in Combination With a GLP-1 Receptor Agonist in Patients With NASH/MASH and Type 2 Diabetes in a Randomized Phase 2 Study

Stephen A. Harrison,Juan P. Frías,et al.

202470 citations

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis

Philip N. Newsome,Arun J. Sanyal,et al.

202313 citations

Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

Marlyn J. Mayo,John M. Vierling,et al.

202333 citations